<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04344405</url>
  </required_header>
  <id_info>
    <org_study_id>Vit D in RA</org_study_id>
    <nct_id>NCT04344405</nct_id>
  </id_info>
  <brief_title>Vitamin D as a Key Player in Rheumatoid Arthritis</brief_title>
  <official_title>Vitamin D as a Key Player in Rheumatoid Arthritis Immune Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rheumatoid arthritis (RA) is a systemic, chronic and inflammatory disease of joints linked to
      autoimmunity. Vitamin D was found to modulate cell growth, function of immune cells and
      anti-inflammatory action. The aim of this study was to investigate serum vitamin D level and
      some cytokines and to identify the correlation between vitamin D and these cytokines in RA.

      Methods: Totally 60 RA patients without vitamin D supplement were involved in this study. The
      serum level of vitamin D, interleukin-6 (IL-6), IL-10, IL-35, tumor necrosis factor α (TNF-α)
      and C-reactive protein (CRP) were measure in all patients by enzyme-linked immunosorbent
      assay (ELISA) then they will divided into 2 groups, group I receive vit. D supplementation
      and group II will receive placebo and follow up for 3 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rheumatoid arthritis (RA) is a systemic, chronic and inflammatory disease of joints linked to
      autoimmunity. Vitamin D was found to modulate cell growth, function of immune cells and
      anti-inflammatory action. The aim of this study was to investigate serum vitamin D level and
      some cytokines and to identify the correlation between vitamin D and these cytokines in RA.

      Methods: Totally 60 RA patients without vitamin D supplement were involved in this study. The
      serum level of vitamin D, interleukin-6 (IL-6), IL-10, IL-35, tumor necrosis factor α (TNF-α)
      and C-reactive protein (CRP) were measure in all patients by enzyme-linked immunosorbent
      assay (ELISA) then they will divided into 2 groups, group I receive vit. D supplementation
      and group II will receive placebo and follow up for 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>DAS 28</measure>
    <time_frame>3 months</time_frame>
    <description>disease activity score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>the Immunomodulatory Effect</condition>
  <arm_group>
    <arm_group_label>Vit D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>vitamin D supplementation</description>
    <arm_group_label>Vit D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  RA patients

        Exclusion Criteria:

          -  Patients with inflammatory bowel disease patients with any other autoimmune diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Manal Hassanien</name>
      <address>
        <city>Assiut</city>
        <state>Assuit</state>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manal Hassanien, MD</last_name>
      <phone>01062679200</phone>
      <email>manal_hassanien@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Abdelraheem Elawamy, MD</last_name>
      <phone>01000032655</phone>
      <email>arawamyyy@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 9, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2020</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Manal Hassanien</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

